{"id":"W4210274145","doi":"10.1016/j.ygyno.2022.01.024","title":"Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Tolerability; Hazard ratio; Internal medicine; Oncology; Discontinuation; Placebo; Ovarian cancer; Cohort; PARP inhibitor; Confidence interval; Cancer; Adverse effect; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007608417,0.0002049514,0.001160467,0.0004868347,0.0001779569,0.000004011613,0.00017699,0.00009327274,0.0003892054],"category_scores_gemma":[0.000269659,0.0001493571,0.00009337131,0.002159472,0.0001878194,0.00003427747,0.0002662236,0.0004468504,5.210313e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00113738,"about_ca_system_score_gemma":0.0003530767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004805538,"about_ca_topic_score_gemma":0.002478835,"domain_scores_codex":[0.9973027,0.0007726722,0.000765963,0.000480604,0.0003585397,0.0003195142],"domain_scores_gemma":[0.9978547,0.0009007857,0.0005913502,0.0003602726,0.0001966841,0.00009619864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02912297,0.009750688,0.8728005,0.00002906386,0.00293836,0.0001754496,0.01810909,0.009984899,0.0029322,0.00006292248,0.0001829366,0.05391093],"study_design_scores_gemma":[0.04778806,0.01307593,0.930646,0.00003954642,0.001234487,0.000005257858,0.005653088,0.0003758405,0.0003536199,0.00001512284,0.0006434536,0.0001695887],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954862,0.00004494266,0.00004403253,0.0006403315,0.0003127036,0.002736013,0.0002222238,0.00002158459,0.0004919684],"genre_scores_gemma":[0.9986023,0.0000214881,0.0001563776,0.0006885123,0.0000191731,0.0003966299,0.00007739491,0.00001470154,0.00002344164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05784551,"threshold_uncertainty_score":0.6090607,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0263865775349412,"score_gpt":0.3524282690015788,"score_spread":0.3260416914666376,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}